951
|
Pollard J, Poenisch F, Sahoo N, Zhu X, Gillin M. SU-GG-T-323: Verification of the Accuracy of the Proton Range Compensator Scatter Factor and Dose within Inhomogeneity Calculations Using the Eclipse Treatment Planning System. Med Phys 2010. [DOI: 10.1118/1.3468719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
952
|
Chen WH, Zhu X, Wu TW, Li RH. Defect solitons in two-dimensional optical lattices. OPTICS EXPRESS 2010; 18:10956-10961. [PMID: 20588951 DOI: 10.1364/oe.18.010956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
We report on the existence and stability of solitons in a defect embedded in a square optical lattice based on a photorefractive crystal with focusing saturable nonlinearity. These solitons exist in different bandgaps due to the change of defect intensity. For a positive defect, the solitons only exist in the semi-infinite gap and can be stable in the low power region but not the high power region. For a negative defect, the solitons can exist not only in the semi-infinite gap, but also in the first gap. With increasing the defect depth, these solitons are stable within a moderate power region in the first gap while unstable in the entire semi-infinite gap.
Collapse
|
953
|
Abstract
Not only are human lenses different in many ways from those of non-primates, they also undergo dramatic changes with age. These age-dependent alterations lead to perturbations in the properties of older lenses, and ultimately to disturbances in visual function, which typically become apparent at middle age. Recent data suggest that many, if not all, of these age-dependent features can be traced to the lack of macromolecular turnover in the lens and to the inexorable modifications to proteins and membrane components over a period of decades. Exposure of lenses to heat can reproduce many of these alterations, suggesting that long-term incubation at body temperature may be an important factor in aging the human lens. Two conclusions flow from this. Firstly, the human lens may be an ideal tissue for studying macromolecular aging in man. Secondly, it will be extremely challenging to examine the origin of human age-related conditions, such as presbyopia and nuclear cataract, using traditional laboratory animals. Characterising the unfolding and decomposition of long-lived macromolecules appears to provide the key to understanding the two most common human lens disorders: presbyopia and age-related nuclear cataract.
Collapse
|
954
|
Li H, Zhu X, Liu S, Xiang J, Chen H. Clusterin immuno-expression and its clinical significance in patients with non-small cell lung cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e17520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
955
|
Hodi FS, O'Day S, McDermott DF, Haanen JB, Robert C, Zhu X, Yellin MJ, Ibrahim RA, Hoos A, Wolchok JD. Re-induction with ipilimumab, gp100 peptide vaccine, or a combination of both from a phase III, randomized, double-blind, multicenter study of previously treated patients with unresectable stage III or IV melanoma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8509] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
956
|
Zhu X, Gaus K, Lu Y, Magenau A, Truscott RJW, Mitchell TW. α- and β-crystallins modulate the head group order of human lens membranes during aging. Invest Ophthalmol Vis Sci 2010; 51:5162-7. [PMID: 20484582 DOI: 10.1167/iovs.09-4947] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE To examine the physical properties of human lens cell membranes as a function of age. METHODS The environment of the phospholipid head groups in fiber cell membranes from human lenses, aged 22 to 83 years, was assessed with Laurdan and two-photon confocal microscopy. The effect of mild thermal stress on head group order was studied with lens pairs in which one intact lens was incubated at 50 °C. Dihydrosphingomyelin vesicles were preloaded with Laurdan, α-, β-, or γ-crystallin was added, and surface fluidity was determined. RESULTS The membrane head group environment became more fluid with age as indicated by increased water penetration. Furthermore, these changes could be replicated simply by exposing intact human lenses to mild thermal stress; conditions which decreased the concentration of soluble α- and β-crystallins. Vesicle binding experiments showed that α- and β-, but not γ-, crystallins markedly affected head group order. CONCLUSIONS The physical properties of cell membranes in the lens nucleus change substantially with age, and α- and β-crystallins may modulate this effect. β-Crystallins may therefore play a role in lens cells, and cells of other tissues, apart from being simple structural proteins. Age-dependent loss of these crystallins may affect membrane integrity and contribute to the dysfunction of lenses in older people.
Collapse
|
957
|
Ranpura V, Pulipati B, Chu D, Zhu X, Wu S. Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens 2010; 23:460-8. [PMID: 20186127 DOI: 10.1038/ajh.2010.25] [Citation(s) in RCA: 167] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND Hypertension is associated with the use of bevacizumab, an angiogenesis inhibitor widely used in cancer therapy. Currently, the risk of severe hypertension associated with bevacizumab is unclear. We performed a systematic review and meta-analysis of published randomized-controlled clinical trials (RCTs) to assess the risk of high-grade hypertension in cancer patients treated with bevacizumab. METHODS Databases from PUBMED, the Web of Science, and abstracts presented at the American Society of Clinical Oncology conferences until May 2009 were searched to identify relevant studies. Eligible studies included prospective RCTs in which bevacizumab was directly compared with controls in cancer patients receiving concurrent antineoplastic therapy. Summary incidence, relative risk (RR), and 95% confidence interval (CI) were calculated employing a fixed- or random-effects model based upon the heterogeneity of the included studies. RESULTS A total of 12,656 patients with a variety of tumors from 20 studies were included for the analysis. The incidence of all-grade hypertension in patients receiving bevacizumab was 23.6% (95% CI: 20.5-27.1) with 7.9% (95% CI: 6.1-10.2) being high-grade (grade 3 or 4). Patients treated with bevacizumab had a significantly increased risk of developing high-grade hypertension with an RR of 5.28 (95% CI: 4.15-6.71, P < 0.001) in comparison with controls. Even though not statistically significant, there was a trend suggesting that bevacizumab may increase the risk of hypertensive crisis (grade 4) with an RR of 3.16 (95% CI: 0.91-10.90). The increased risk of high-grade hypertension was observed in patients receiving bevacizumab at 2.5 mg/kg/week (RR = 4.78, 95% CI: 3.59-6.36) as well as 5 mg/kg/week (RR = 5.39, 95% CI: 3.68-7.90). The risk of high-grade hypertension may vary with tumor types, with RRs ranging from 2.49 (95% CI: 0.94-6.59) in patients with mesothelioma to 14.80 (95% CI: 0.92-238.51) in patients with breast cancer. CONCLUSION Bevacizumab may significantly increase the risk of high-grade hypertension in cancer patients. Close monitoring and adequate management are highly recommended to decrease cardiovascular complications.
Collapse
|
958
|
Qiu Y, Zhu X, Wang W, Xu Q, Ding Y. Nutrition support with glutamine dipeptide in patients undergoing liver transplantation. Transplant Proc 2010; 41:4232-7. [PMID: 20005375 DOI: 10.1016/j.transproceed.2009.08.076] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2008] [Revised: 03/30/2009] [Accepted: 08/04/2009] [Indexed: 11/19/2022]
Abstract
AIM The effect of total parenteral nutrition (TPN) support supplemented with alanyl-glutamine (Ala-Gln) dipeptide was investigated in a randomized, controlled clinical trial. METHODS Sixty-five patients with the diagnosis of end-stage liver disease or hepatic cellular carcinoma admitted for orthotopic liver transplantation were randomly divided into 3 groups: diet group (n = 21), TPN group (n = 22), and Gln group (n = 22). Patients in the TPN and Gln groups received isocaloric and isonitrogenous TPN for 7 days. Venous heparin blood samples were obtained for assay on days 2 and 9 after surgery; we performed routine pathologic tests. RESULTS Compared with the results on day 9 in the TPN group, there was a significant increase in the prognostic nutrition index and in prealbumin among the Gln group. Aspartate aminotransferase improved significantly by Gln treatment compared with traditional TPN support (P < .05). The pathologic results also showed Gln supplementation to reduce hepatic cell injury. A significant decrease in postoperative hospital stay was observed in the Gln group. CONCLUSIONS Posttransplant TPN support greatly improved protein metabolism and nutritional state of patients. TPN with Ala-Gln helped to improve synthetic function and to reduce the injury to a transplanted liver.
Collapse
|
959
|
Pang R, Zhang Y, Pan X, Gu R, Hou X, Xiang P, Liu Z, Zhu X, Hu J, Zhao J, Zhang C. Embryonic-like stem cell derived from adult bone marrow: immature morphology, cell surface markers, ultramicrostructure and differentiation into multinucleated fibers in vitro. Cell Mol Biol (Noisy-le-grand) 2010; 56 Suppl:OL1276-OL1285. [PMID: 20385079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2009] [Accepted: 02/15/2010] [Indexed: 05/29/2023]
Abstract
Embryonic-like stem cell (ELSC), expressing part of surface markers of human embryonic stem cells, may be a better candidate for cell therapy of degenerative muscular disease than mesenchymal stem cell (MSC). We isolated ELSC and MSC from bone marrow, respectively, and compared their differences in the characteristics and the capacity of myogenic differentiation. Results showed that ELSC could be isolated successfully from 3 adult bone marrow samples by using serum-free medium with 10ng/ml basic fibroblast growth factor (bFGF). At the same cell density, MSC could also be isolated from the same samples by using DMEM/F12 medium containing 10% new cattle serum. However, ELSC appeared as small, morphologically slenderer, upregulated expression of SSEA-4 and ultramicroscopically more immature than MSC derived from the same samples. Immunofluorescent staining and RT-PCR analysis showed ELSC weakly expressed Oct-4, Nanog-3 and Sox-2. Moreover, ELSC and MSC could be induced into long, multinucleated fibers expressing myogenin and myosin heavy chain (MHC) in myogenic differentiation medium, but by day 10, proportion of multinucleated fibers positive for MHC was respectively 25.0%+/-6.9% and 13.8%+/-7.6% in ELSC and MSC culture. These data suggest that bone marrow derived ELSC represent an ideal candidate for cell therapy of degenerative muscular disease.
Collapse
|
960
|
Abelev BI, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Baumgart S, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bonner BE, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Calderon M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Clarke RF, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Das D, Dash S, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, DePhillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elhalhuli E, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Gupta A, Gupta N, Guryn W, Haag B, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Konzer J, Kopytine M, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, Levine MJ, Li C, Li L, Li N, Li W, Li X, Li Y, Li Z, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mal OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitrovski MK, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Sahoo R, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sangaline E, Schambach J, Scharenberg RP, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbaek F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wingfield E, Wissink SW, Witt R, Wu Y, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang J, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao J, Zhong C, Zhou J, Zhou W, Zhu X, Zhu YH, Zoulkarneev R, Zoulkarneeva Y. Observation of an Antimatter Hypernucleus. Science 2010; 328:58-62. [DOI: 10.1126/science.1183980] [Citation(s) in RCA: 209] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
961
|
Zhu X, Schülzgen A, Li H, Wei H, Moloney JV, Peyghambarian N. Coherent beam transformations using multimode waveguides. OPTICS EXPRESS 2010; 18:7506-7520. [PMID: 20389773 DOI: 10.1364/oe.18.007506] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Physical insights and characteristics of beam transformations based on multimode interference (MMI) in multimode waveguides are illuminated and analyzed. Our calculations show that, utilizing a short piece of cylindrical multimode waveguide, an input Gaussian beam can be readily transformed to frequently desired beams including top-hat, donut-shaped, taper-shaped, and Bessel-like beams in the Fresnel or the Fraunhofer diffraction range, or even in both ranges. This is a consequence of diffractive propagation of the field exiting the waveguide. The performance of the beam shaper based on MMI can be controlled via tailoring the dimensions of the multimode waveguide or changing the signal wavelength. This beam shaping technique is investigated experimentally using monolithic fiber devices consisting of a short piece of multimode fiber (approximately 10 mm long) and a single-mode signal delivery fiber.
Collapse
|
962
|
Lu B, Gong W, Yang Z, Yang Z, Yang Y, Wen J, Zhao N, Zhu X, Hu R. An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus. J Int Med Res 2010; 37:1493-500. [PMID: 19930856 DOI: 10.1177/147323000903700526] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The concomitant presence of retinopathy may be helpful in discriminating kidney pathology in type 2 diabetes. This cross-sectional study evaluated the ability to predict the likelihood of patients having diabetic kidney disease (DKD) by comparing the percentage incidence of diabetic retinopathy in different subgroups of Chinese patients with type 2 diabetes (n = 668). The prevalence of chronic kidney disease in the patients was 63.3% (6.6% with DKD, 41.0% with possible DKD and 15.7% with non-diabetic renal disease [NDRD]). The percentage of patients with diabetic retinopathy in the DKD group (63.6%) was significantly higher than in the possible DKD group (24.9%) and the NDRD group (19.0%). DKD was independently associated with diabetic retinopathy based on logistic regression analysis. The likelihood of DKD occurrence as defined by the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative of the USA is applicable to Chinese patients with diabetes. Diabetic retinopathy was more prevalent in patients with DKD compared with patients with possible DKD or NDRD.
Collapse
|
963
|
Gershkovich P, Wasan EK, Sivak O, Li R, Zhu X, Werbovetz KA, Tidwell RR, Clement JG, Thornton SJ, Wasan KM. Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice. J Antimicrob Chemother 2010; 65:535-537. [DOI: 10.1093/jac/dkp465] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
|
964
|
Zhu X, Chen J, Han F, Cheng M, Xu L, Zhang L, Ding X, Le Y. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study. Transplant Proc 2010; 41:3736-42. [PMID: 19917377 DOI: 10.1016/j.transproceed.2009.06.225] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2008] [Revised: 04/28/2009] [Accepted: 06/01/2009] [Indexed: 10/20/2022]
Abstract
BACKGROUND Hyperuricemia and posttransplantation erythrocytosis (PTE) are frequent complications after kidney transplantation and are important risk factors for cardiovascular events. Losartan decreases serum uric acid and hemoglobin (Hb) concentrations and may be a useful agent for treatment of hyperuricemia and PTE. OBJECTIVE To evaluate the influence of losartan on serum creatinine (SCr), serum uric acid, and hemoglobin (Hb) concentrations in patients after kidney transplantation and to evaluate the safety profile of losartan in these patients. PATIENTS AND METHODS Sixty-six Han Chinese patients (43 men and 23 women; mean [SD] age, 40.45 [11.50] years) were enrolled in the study. All patients had undergone a first cadaveric donor kidney transplantation at least 3 months previously and had stable graft function with SCr concentration less than 176.8 micromol/L and Hb concentration greater than 110 g/L. The patients were divided into 2 groups (losartan group, n = 34; and control group, n = 32) according to the odevity of patient identification number. Patients in the losartan group received losartan, 50 mg/d; patients in the control group did not receive losartan. Each patient was followed up for 6 months. RESULTS Nine patients in the losartan group and 5 patients in the control group dropped out because of acute renal insufficiency, anemia, acute rejection, or poor compliance. The serum uric acid concentration in the losartan group continuously decreased at months 1, 2, 3, and 6 (P = .12, P = .01, P = .04, and P = .005 compared with baseline, and P = .02, P = .003, P = .02, and P = .006 compared with control), especially in the patients with hyperuricemia (P = .02, P < .001, P = .003, and P < .001 compared with baseline, and P = .02, P = .002, P = .02, and P = .002 compared with control). The Hb level in the losartan group decreased significantly at months 1, 2, 3, and 6 (P = .003, P < .001, P = .004, and P = 0.02 compared with baseline, and P = .001, P < .001, P = .001, and P = .005 compared with control), especially in patients with PTE. In patients without PTE, there was no significant decline in Hb concentration in the losartan group compared with baseline. There was no significant decline in estimated glomerular filtration rate in the losartan group. CONCLUSIONS Losartan may be an effective agent for treatment of hyperuricemia and PTE in Han Chinese patients after kidney transplantation. However, in some patients, losartan may not be safe.
Collapse
|
965
|
Wang X, Sun W, Zhu X, Li L, Du T, Mao W, Wu X, Wei H, Zhu S, Sun Y, Liu Y, Niu N, Wang Y, Liu Y. Paroxysmal kinesigenic choreoathetosis: evidence of linkage to the pericentromeric region of chromosome 16 in four Chinese families. Eur J Neurol 2010; 17:800-7. [PMID: 20158512 DOI: 10.1111/j.1468-1331.2009.02929.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Paroxysmal kinesigenic choreoathetosis (PKC) is an autosomal dominant condition characterized by abnormal involuntary movements precipitated by sudden movement. The pericentromeric region of chromosome 16 has been linked to PKC by several reports. This study was to localize and identify PKC gene in four Chinese PKC families. METHODS Genetic linkage mapping with eight markers spanning chromosome 16p12-q13 was performed in 43 family members. Genome-wide single nucleotide polymorphism (SNP) scans were performed on four individuals in Family 1 in which infantile convulsion (IC) was co-inherited with PKC. RESULTS Individuals in Family 1 presented with both IC and paroxysmal choreoathetosis (ICCA), and Families 2, 3, and 4 presented only with PKC. Evidence for linkage was found with a maximum two-point LOD score of 4.89 for D16S690 (theta = 0.0) and a maximum multipoint LOD score was 5.34 between D16S3080 and D16S3136. Haplotype analysis showed the disease locus was between D16S3093 and D16S3057. A total of 84 SNPs spanned on 16q12.1-q13 was not segregated with the PKC phenotype, which defined an unlinked region from rs9933187 to rs8044753. Thus, the critical region of the PKC gene is across the pericentromeric region of chromosome 16, and most likely maps to a region of 20.5 Mb (6.2 cM) between D16S3093 and rs9933187 (16p11.2-q12.1). CONCLUSION The assignment of the locus for PKC to the pericentromeric region of chromosome 16 is confirmed and putatively narrowed in the present study.
Collapse
|
966
|
Zhu X, Mavi P, Rayapudi M, Mishra A. Indoor Insect Allergens Are Potent Inducers of Esophageal and Pulmonary Inflammation. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
967
|
Zhu X, Tam M, McLennan G, Sands M, Wang W. Abstract No. 3: Indications, complications and outcomes of G2 retrievable IVC filters in 765 patients: A single institute experience. J Vasc Interv Radiol 2010. [DOI: 10.1016/j.jvir.2009.12.144] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
968
|
Go K, Pribis J, Bryk J, Rominski S, Zhu X, Ochoa J. Prostaglandins Synergize to Increase Arginase Activity in Trauma-Induced Myeloid Derived Suppressor Cells (TI-MDSC). J Surg Res 2010. [DOI: 10.1016/j.jss.2009.11.766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
969
|
Forbes L, Ducka B, Fehrenbach M, Hortobagyi L, Zhu X, Kierstein S, Sharma S, Haczku A. Surfactant Protein D (SP-D) Binds to Signal Regulatory Protein Alpha (SIRP-α) on Alveolar Macrophages and Dendritic Cells and Promotes Allergen-Induced Lymph-Node Directed Migration. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
970
|
Tam M, Zhu X, McLennan G, Sands M, Wang W. Abstract No. 2: Complications of the Bard Recovery filter and their effect on attempted retrieval in 107 patients. J Vasc Interv Radiol 2010. [DOI: 10.1016/j.jvir.2009.12.143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
971
|
Xiao H, Lai X, Wu G, Luo Y, Shi J, Tan Y, Han X, Zhu X, Zhu J, Xie W, He J, Cai Z, Lin M, Ye X, Huang H. Immunosuppressive Cytokine Gene Polymorphisms And Outcomes After Related And Unrelated Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2010. [DOI: 10.1016/j.bbmt.2009.12.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
972
|
Bonda DJ, Bajić VP, Spremo-Potparevic B, Casadesus G, Zhu X, Smith MA, Lee HG. Review: cell cycle aberrations and neurodegeneration. Neuropathol Appl Neurobiol 2010; 36:157-63. [PMID: 20059701 DOI: 10.1111/j.1365-2990.2010.01064.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The cell cycle is a highly regulated and fundamental cellular process that involves complex feedback regulation of many proteins, and any compromise to its integrity elicits dire consequences for the cell. For example, in neurodegenerative diseases such as Alzheimer disease (AD), evidence for abnormal cell cycle re-entry precedes other hallmarks of disease and as such, implicates cell cycle aberrations in the aetiology of AD. The mechanism(s) for cell cycle re-entry in AD, however, remain unclear. Current theory suggests it to be part of a combination of early events that together elicit the degenerative pathology and cognitive phenotype consistent with the disease. We propose a 'Two-Hit Hypothesis' that highlights the concerted interaction between cell cycle alterations and oxidative stress that combine to produce neurodegeneration. Here, we review the evidence implicating cell cycle mechanisms in AD and how such changes, especially in combination with oxidative stress, would lead to a cascade of events leading to disease. Based on this concept, we propose new opportunities for disease treatment.
Collapse
|
973
|
Favreau F, Thuillier R, Cau J, Milin S, Manguy E, Mauco G, Zhu X, Lerman LO, Hauet T. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2010; 10:30-9. [PMID: 19958330 PMCID: PMC2807130 DOI: 10.1111/j.1600-6143.2009.02924.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Ischemia reperfusion injury (IRI) is pivotal for renal fibrosis development via peritubular capillaries injury. Coagulation represents a key mechanism involved in this process. Melagatran (M), a thrombin inhibitor, was evaluated in an autotransplanted kidney model, using Large White pigs. To mimic deceased after cardiac death donor conditions, kidneys underwent warm ischemia (WI) for 60 min before cold preservation for 24 h in University of Wisconsin solution. Treatment with M before WI and/or in the preservation solution drastically improved survival at 3 months, reduced renal dysfunction related to a critical reduction in interstitial fibrosis, measured by Sirius Red staining. Tissue analysis revealed reduced expression of transforming growth factor-beta (TGF-beta) and activation level of its effectors phospho-Smad3, Smad4 and connective tissue growth factor (CTGF) after M treatment. Fibrinolysis activation was also observed, evidenced by downregulation of PAI-1 protein and gene expression. In addition, M reduced S100A4 expression and vimentin staining, which are markers for epithelial mesenchymal transition, a major pathway to chronic kidney fibrosis. Finally, expression of oxidative stress markers Nox2 and iNOS was reduced. We conclude that inhibition of thrombin is an effective therapy against IRI that reduces chronic graft fibrosis, with a significantly positive effect on survival.
Collapse
|
974
|
Abelev BI, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bnzarov I, Bonner BE, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Bruna E, Bueltmann S, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Clarke RF, Codrington MJM, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, De Silva LC, Dedovich TG, DePhillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dzhordzhadze V, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elhalhuli E, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Huo L, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Konzer J, Kopytine M, Koralt I, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li N, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Schambach J, Scharenberg RP, Schmitz N, Seele J, Seger J, Selyuzhenkov I, Semertzidis Y, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbaek F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zhu X, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Azimuthal charged-particle correlations and possible local strong parity violation. PHYSICAL REVIEW LETTERS 2009; 103:251601. [PMID: 20366248 DOI: 10.1103/physrevlett.103.251601] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/10/2009] [Indexed: 05/29/2023]
Abstract
Parity-odd domains, corresponding to nontrivial topological solutions of the QCD vacuum, might be created during relativistic heavy-ion collisions. These domains are predicted to lead to charge separation of quarks along the system's orbital momentum axis. We investigate a three-particle azimuthal correlator which is a P even observable, but directly sensitive to the charge separation effect. We report measurements of charged hadrons near center-of-mass rapidity with this observable in Au + Au and Cu + Cu collisions at square root of s(NN) = 200 GeV using the STAR detector. A signal consistent with several expectations from the theory is detected. We discuss possible contributions from other effects that are not related to parity violation.
Collapse
|
975
|
|